Send feedback

CSN2 p.Val39Phe

c.115G>T · rs1723485421 · VCV2484927

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.1212 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.55e-05%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.1212likely benign
REVEL0.212benign-leaning
SaProtLLR -6.69tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.8GERP -3.8
Regional constrainto/e 1.26unconstrained · MANE · 4,642 bp · p 2.6e-05 · regional, not allelic
Overall
CADD4.457PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.55e-05% European (non-Finnish) · 1/1,168,932 alleles
Overall 6.92e-05% 1/1,446,046 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CSN2
Protein
p.Val39Phe
Coding
c.115G>T
MANE Select
NM_001891
dbSNP
rs1723485421
Type
single nucleotide variant
Location
chr4:69958938 (GRCh38)
Gene constraint
LOEUF 1.168 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 60.09
Full CSN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/csn2-p-val39phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown